Growth Opportunities in Digital, Microbiome-based, and Preventive Healthcare Technologies, 2020 Report – Focus on Latest Advancements for Chronic Pain Management and COVID-19 Testing – ResearchAndMarkets.com

Growth Opportunities in Digital, Microbiome-based, and Preventive Healthcare Technologies, 2020 Report – Focus on Latest Advancements for Chronic Pain Management and COVID-19 Testing – ResearchAndMarkets.com




Growth Opportunities in Digital, Microbiome-based, and Preventive Healthcare Technologies, 2020 Report – Focus on Latest Advancements for Chronic Pain Management and COVID-19 Testing – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Digital, Microbiome-based, and Preventive Healthcare Technologies 2020” report has been added to ResearchAndMarkets.com’s offering.

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations in digital health, microbiome, and flu vaccines technologies. The TOE also provides insights across latest advancements for chronic pain management and COVID-19 testing.

The TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Key Topics Covered:

  1. Molomics, Barcelona, Spain – Growth Opportunities
  2. Repurpose.AI, US – Growth Opportunities
  3. Cyclica Rx, Canada – Growth Opportunities
  4. Biondvax, Israel – Growth Opportunities
  5. Flugen Inc. US – Growth Opportunities
  6. Imutex, UK – Growth Opportunities
  7. Blue Water Vaccines Inc. US – Growth Opportunities
  8. Seqirus Ltd. UK – Growth Opportunities
  9. Iqur Limited, UK – Growth Opportunities
  10. Osivax, France – Growth Opportunities
  11. Vivaldi Biosciences, US – Growth Opportunities
  12. Emergex Vaccines Holding Ltd. UK – Growth Opportunities
  13. Adagio Therapeutics, US – Growth Opportunities
  14. Iggenix, US – Growth Opportunities
  15. Duke-Nus Medical School, Singapore – Growth Opportunities
  16. Biorelate, UK – Growth Opportunities
  17. Pieriandx, US – Growth Opportunities
  18. Blackthorn Therapeutics, US – Growth Opportunities
  19. Sangamo Therapeutics Inc. US – Growth Opportunities
  20. Seres Therapeutics Inc. US – Growth Opportunities
  21. American Gene Technologies Inc. US – Growth Opportunities
  22. F2G, UK – Growth Opportunities
  23. Kineta, US – Growth Opportunities
  24. DNA Script, France – Growth Opportunities
  25. Reapplix A/S, Denmark – Growth Opportunities
  26. Novozymes, Denmark – Growth Opportunities

For more information about this report visit https://www.researchandmarkets.com/r/v6l8dq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900